Cargando…
Effect of CPAP therapy on kidney function in patients with obstructive sleep apnoea and chronic kidney disease: a protocol for a randomised controlled clinical trial
INTRODUCTION: Obstructive sleep apnoea (OSA) is common in patients with chronic kidney disease (CKD) and may contribute to the progression of kidney disease either through direct effects of hypoxia on the kidney or indirectly through hypoxaemia-induced oxidative stress, endothelial dysfunction, infl...
Autores principales: | Rimke, Alex N, Ahmed, Sofia B, Turin, Tanvir C, Pendharkar, Sachin R, Raneri, Jill K, Lynch, Emma J, Hanly, Patrick J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475212/ https://www.ncbi.nlm.nih.gov/pubmed/30904853 http://dx.doi.org/10.1136/bmjopen-2018-024632 |
Ejemplares similares
-
Nocturnal sweating—a common symptom of obstructive sleep apnoea: the Icelandic sleep apnoea cohort
por: Arnardottir, Erna Sif, et al.
Publicado: (2013) -
Use of CPAP to reduce arterial stiffness in moderate-to-severe obstructive sleep apnoea, without excessive daytime sleepiness (STIFFSLEEP): an observational cohort study protocol
por: Mineiro, Maria Alexandra, et al.
Publicado: (2016) -
Evaluation of an alternative care provider clinic for severe sleep-disordered breathing: a study protocol for a randomised controlled trial
por: Ip-Buting, Ada, et al.
Publicado: (2017) -
Non-CPAP therapy for obstructive sleep apnoea
por: Verbraecken, Johan, et al.
Publicado: (2022) -
Effect of acetazolamide on obstructive sleep apnoea in highlanders: protocol for a randomised, placebo-controlled, double-blinded crossover trial
por: Tan, Lu, et al.
Publicado: (2022)